Epista Life Science A/S: Financial statements 2013
CVR: 32141064
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
Epista Life Science A/S (CVR 32141064) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK 10,851,968 and a net result of DKK 1,522,575 compared with DKK 470,832 the year before. That is an increase of 39.4% compared with the year before. Equity in the 2013 report amounted to DKK 1,200,612. The solvency ratio was 23.3%.
- Gross Profit
- DKK 10,851,968
- Profit/Loss
- DKK 1,522,575
- Equity
- DKK 1,200,612
- Total Assets
- DKK 5,160,516
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
As of September 30, 2013, Mette Pilmann Esbjerg has joined the board of directors of Epista Life Science A/S.
As of September 30, 2013, Klavs Esbjerg has joined the board of directors of Epista Life Science A/S.
As of September 30, 2013, Ken Rasmussen has joined the board of directors of Epista Life Science A/S.
On September 30, 2013, the company changed its name from EPISTA IT ApS to EPISTA IT A/S.
Epista Life Science A/S has published its annual report for 2012. Gross profit came to DKK 7,785,482, and the net result was DKK 470,832.
About Epista Life Science A/S
Epista Life Science A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2009. The company is registered under the industry Computerkonsulentbistand og forvaltning af computerfaciliteter. The company was previously named EPISTA IT A/S and EPISTA IT ApS. The management consists of Per Erik Mikael Johansson. The board consists of Simon Carl Vilhelm Larsson (chair), Katarína Larsen and Klavs Esbjerg. The company is owned by Enhance BidCo ApS. The company has 86 employees (2026). In 2025, the company reported a gross profit of DKK 104,009,512 and a net result of DKK -40,340,814 compared with DKK -12,458,230 the year before. Equity in the 2025 report amounted to DKK 42,811,282.
